GENE ONLINE|News &
Opinion
Blog

2017-12-19|

December 20, 1958: American Developmental Biologist James Thomson was Born

by GeneOnline
Share To

James Alexander Thomson (December 20, 1958 – present) is a famous American developmental biologist who derived the first human embryonic stem cell line in 1998, and is also one of the pioneering scientists who developed human induced pluripotent stem cells (iPS) in 2007. His work of human embryonic stem cells drew attention to the regenerative and repairing ability of stem cells.

Reference
https://en.wikipedia.org/wiki/James_Thomson_(cell_biologist)

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Author
GeneOnline
Related Post
R&D
Fifth HIV Patient Cured After Stem Cell Transplant in Germany
2023-03-01
Innovation
Human “Mini-Brains” Transplantation Shows a Way to Cure Blindness
2023-02-09
R&D
How Genetics Might Affect PTSD Susceptibility
2022-10-27
LATEST
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
READ MORE
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top